It is a type of fusion gene. It has been found that 50-70% of prostate cancers are from TMPRSS2-ETS fusion prostate cancers. (1)
References:
Mosquera, J. M. et al., Morphological features of TMPRSS2-ERG gene fusion prostate cancer. Journal of Pathology, 2007 May; Volume 212 (1): pp. 91-101..
-
Q: What do you know about ergot alkaloids? Ans: These include alkaloids which we get from the ergot fungus Claviceps purpurea or derived ...
-
(For detailed study of Pharmaceutical Incompatibility Click here) Multiple Choice Questions (MCQs) from Pharmaceutical Incompatibility in ...
No comments:
Post a Comment